N Latex Cystatin C
Test, Cystatin C. 510(k) K003503, from Dade Behring, Inc. (P.O. Box 6101, Newark, DE). Product code NDY, class 2.
As of Nov 20, 2026, K003503 is an FDA 510(k) held by Dade Behring, Inc., substantially equivalent on Mar 13, 2001 after 120 days, with no recalls tied to it in FDA's recall database.
- Review time: 120 days
- Recalls: 0
- Cited as a predicate by: 3 devices
- Gentian Cystatin C ImmunoassayK071388 · Gentian AS · Nov 6, 2007
- N Latex CystatinK041878 · Dade Behring, Inc. · Aug 16, 2004
- Cystatin C Immunoparticles, Control Set, CalibratorK041627 · Dako A/S · Sep 3, 2004
- Cystatin CK242585 · SENTINEL CH. SpA · May 16, 2025
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Nov 13, 2000
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1225
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files